Free press releases distribution network?

More news: Health/Surgery
Agency / Source: AdvaCare Pharma

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



AdvaCare Publishes Antimalarial Solutions for a Global Epidemic Problem - Malaria is a global disease that half of the world's population is susceptible to. Not only does it present health but also economic consequences. AdvaCare endeavors to provide the medications and test kits in the fight to alleviate this epidemic
AdvaCare Publishes Antimalarial Solutions for a Global Epidemic Problem

 

PRZOOM - /newswire/ - Shanghai, China, 2013/04/19 - Malaria is a global disease that half of the world's population is susceptible to. Not only does it present health but also economic consequences. AdvaCare endeavors to provide the medications and test kits in the fight to alleviate this epidemic.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

There are some alarming statistics regarding Malaria. Geographically, half of the world’s population is at risk for contracting Malaria. It is an endemic disease spreading around the equator, inflicting fatalities (85-90%) in Sub-Saharan Africa. According to the Malaria Atlas Project(2010), as many as 100 countries are highly at risk. Every year, 125 million international travelers visit these countries, and more than 30,000 become infected. In 2010, the World Health Organization estimated that between 660,000 to 1.2million people died from Malaria. That is about 2,000 to 3,000 deaths per day, or one child every 30 seconds; those under the age of five with less developed immune systems are most susceptible.

So what is Malaria? It is a parasitic disease transmitted by Anopheles mosquitoes infected by the plasmodium parasites. These parasites lodge in the liver to mature and multiply. Within a month, 40,000 replications burst out infecting oxygen bearing red blood cells. What begins as flu-like symptoms could lead to life-threatening conditions such as brain damage, severe anemia, and kidney failure. Survivors are often left with permanent neurological damage.

Various strains of the plasmodium parasite exist but the vast majority of deaths are caused by P. falciparum and P. vivax. AdvaCare’s AccuQuik range of medical test kits including Malaria Pf & Pv Antibody Rapid Test specifically target these 2 dangerous strains. This 1-step test kit is simple and reliable with accurate qualitative results obtainable in just 10 to 15 minutes. Produced according to ISO 13485 and ISO 9001 standards, they are available as strips or cassettes, and could also be manufactured under a client’s brand name and custom-packaged according to their specifications.

Artemisinin based medications are the drug of choice amongst antimalarials. When paired with another antimalarial, it is known as Artemisinin-Combination Therapy(ACT). This reduces the development of resistance in the parasite to any single drug component. A prime example of ACT is AdvaCare’s Artemether and Lumefantrine Tablets. This potent combination achieves cure rates of up to 95% even in cases of multi-drug resistance. Another recommended combination is Dihydroartemisinin and Piperaquine Powder for Suspension which is about 90% effective when used to treat uncomplicated malaria. Well tolerated with less adverse side effects even in children, it also has the benefit of superior protection against recurrence of P. falciparum. Where oral ingestion of medication is ineffective or difficult to administer, AdvaCare’s Artemether Injection, provides an intravenous or intramuscular solution. Targeting both strains of malarial parasites, it is available as a mono-therapy but more commonly used in combination with another antimalarial. AdvaCare’s brand, ArteCare, is a leading product in most countries with high infection rates for malaria.

Increased malaria prevention and control measures have dramatically reduced this epidemic in many places. Malaria mortality rates have fallen by more than 25% globally since 2000 and by 33% in the WHO African Region. Early diagnosis and treatment of malaria reduces disease and prevents deaths. It also contributes to reducing transmission. Prevention, achievable through the spread of awareness and the adoption of measures such as sleeping under long-lasting insecticidal nets protects against malaria. To these ends, AdvaCare is a stakeholder in the fight against malaria.

Four of AdvaCare’s antimalarials (advacarepharma.com) are featured in our March newsletter campaign. To be placed on this newsletter’s mailing list, please submit an email address under “Newsletter” in the “Contact” section on AdvaCarePharma’s website. This newsletter will be very beneficial to those who are interested in learning about products that have the best price. These products will include finished pharmaceuticals, veterinary and medical disposables. AdvaCare’s newsletter will be the only way to take advantage of these special deals and discounts.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: AdvaCare Pharma

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


AdvaCare Publishes Antimalarial Solutions for a Global Epidemic Problem

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Bradley Johnson - AdvaCarePharma.com 
+86 2161473476 sales[.]advacarepharma.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any AdvaCare Pharma securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From AdvaCare Pharma / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Ultimate Medical Group Announces A New Regenerative Medicine Division

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  NAKIVO, Inc.

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today